scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12031-011-9591-6 |
P698 | PubMed publication ID | 21732076 |
P50 | author | Nicola M. Woodroofe | Q45349823 |
P2093 | author name string | G Alkistis Frentzou | |
Kirsty A Harkness | |||
Alison K Cross | |||
Gail Haddock | |||
Claire Bradford | |||
P2860 | cites work | Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia | Q41924531 |
Glutamate, interleukin-6, and early clinical worsening in patients with acute stroke | Q43599433 | ||
Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. | Q43935582 | ||
Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target | Q43948946 | ||
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow | Q44802862 | ||
Inflammatory biomarkers in blood of patients with acute brain ischemia | Q44894573 | ||
Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. | Q47696860 | ||
Interleukin-1 exacerbates focal cerebral ischemia and reduces ischemic brain temperature in the rat. | Q47764426 | ||
Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1beta in the cerebral cortex | Q47772233 | ||
Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. | Q48386811 | ||
Cerebral vessels express interleukin 1beta after focal cerebral ischemia | Q48481212 | ||
ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes | Q48573517 | ||
IL-6: an early marker for outcome in acute ischemic stroke | Q48899503 | ||
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia | Q49021460 | ||
Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia. | Q53516284 | ||
Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. | Q55066475 | ||
Thrombotic thrombocytopenic purpura | Q57591162 | ||
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure* | Q58481438 | ||
Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. | Q64907051 | ||
Interleukin-1 beta mRNA expression in ischemic rat cortex | Q72595870 | ||
Proinflammatory cytokines and early neurological worsening in ischemic stroke | Q73048866 | ||
Attenuation and augmentation of ischaemia-related neuronal death by tumour necrosis factor-alpha in vitro | Q73167494 | ||
Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery | Q81318143 | ||
Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family | Q24291639 | ||
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura | Q24291691 | ||
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome | Q24794415 | ||
Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells | Q24804694 | ||
Regulation of chemokine receptor expression in human microglia and astrocytes | Q28181079 | ||
Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells | Q28564426 | ||
Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo | Q28584350 | ||
Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders | Q33338836 | ||
Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome | Q33345187 | ||
Transcriptional regulation of ADAMTS13. | Q33368015 | ||
Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. | Q33368680 | ||
Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children | Q33380064 | ||
TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells | Q33389698 | ||
Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition | Q33419829 | ||
Dual role of tumor necrosis factor alpha in brain injury | Q33879032 | ||
Proinflammatory cytokines | Q33913139 | ||
Role of IL-1alpha and IL-1beta in ischemic brain damage. | Q34084693 | ||
Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains | Q34116077 | ||
Strategies for metabolic exchange between glial cells and neurons | Q34460241 | ||
Signalling pathways mediating inflammatory responses in brain ischaemia | Q34572203 | ||
ADAMTS13 is expressed in hepatic stellate cells | Q36950896 | ||
Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat | Q36983198 | ||
Interleukin-1beta: a bridge between inflammation and excitotoxicity? | Q37100241 | ||
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage | Q37460371 | ||
The two different receptors for tumor necrosis factor mediate distinct cellular responses | Q37609601 | ||
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3. | Q39670075 | ||
Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment | Q39867777 | ||
Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts | Q40295329 | ||
TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function | Q40928269 | ||
Interleukin-1 beta stimulates mitogen-activated protein kinase in U373 astrocytoma cells without the production of lipid second messengers | Q41063844 | ||
Von Willebrand factor: molecular size and functional activity | Q41079759 | ||
P433 | issue | 2 | |
P304 | page(s) | 343-351 | |
P577 | publication date | 2011-07-06 | |
P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
P1476 | title | IL-1β down-regulates ADAMTS-13 mRNA expression in cells of the central nervous system | |
P478 | volume | 46 |
Q41681165 | Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow |
Q40920543 | Increased expressions of ADAMTS-13 and apoptosis contribute to neuropathology during Toxoplasma gondii encephalitis in mice |
Q35584353 | Increased expressions of ADAMTS-13, neuronal nitric oxide synthase, and neurofilament correlate with severity of neuropathology in Border disease virus-infected small ruminants |
Q58755718 | The human microglial HMC3 cell line: where do we stand? A systematic literature review |